Clinical genetics is an ever-changing field of medicine that has undergone significant advancements. Therefore, efforts to identify the critical components of a comprehensive cancer risk assessment are imperative. The combined approach of thorough information gathering, effective genetic counseling, and continued post-testing management has been adopted as a strategic approach to risk assessment.
Disclosures: Dr. Hall has disclosed serving as a scientific advisor for Eisai Inc., and Natera Inc.